Overview
Portfolio
More
Meridian Health Ventures
London, United Kingdom
First NHS‑anchored, transatlantic VC fund investing in clinical innovators and scaling transformative health solutions.
Portfolio
18+
Employees
10+
Founded
2021
AUM
≈ $88.5M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United KingdomNorth America
Fund details
Funds
Meridian Health Ventures I
Vintage 2025 • $39.4M
Meridian Health Ventures II
Vintage 2025 • $49.2M
Sources
Meridian Health Ventures
First NHS‑anchored, transatlantic VC fund investing in clinical innovators and scaling transformative health solutions.
Portfolio
18+
Employees
10+
Founded
2021
AUM
≈ $88.5M
Funds
Meridian Health Ventures I · Vintage 2025 • $39.4M
Meridian Health Ventures II · Vintage 2025 • $49.2M
Stages
No stages listed
Industries
No industries listedGeographic scope
United KingdomNorth America
Sources
Showing 18 of 18 matched portfolio companies
52North develops in-vitro diagnostic and digital solutions aimed at improving the safety and effectiveness of emergency care. Their product portfolio includes Neutrocheck®, a portable blood test for identifying neutropenic sepsis risk, and ACORN™, a digital tool for remote triage in emergency cancer care. The company leverages its Aster™ platform for rapid, multiplexed cell measurement from single samples.
Funding: $6.9M
Rough estimate of the amount of funding raised
Funding: $6.9M
Rough estimate of the amount of funding raised
Acorai manufactures a non-invasive intracardiac pressure monitoring device that utilizes a unique combination of seismic, acoustic, visual, and electric sensors to provide accurate and actionable insights for heart failure management. This technology enables healthcare professionals to make informed decisions based on continuous monitoring, ultimately improving patient outcomes and reducing readmission rates.
Funding: $13.2M
Rough estimate of the amount of funding raised
Funding: $13.2M
Rough estimate of the amount of funding raised
Acurable develops wearable medical devices that utilize advanced signal processing algorithms to record and analyze physiological sounds for the diagnosis and management of respiratory conditions, including obstructive sleep apnea. The AcuPebble™ Ox100, an FDA-cleared home sleep testing device, enables patients to monitor their health conveniently and accurately from home.
Funding: $13.5M
Rough estimate of the amount of funding raised
Funding: $13.5M
Rough estimate of the amount of funding raised
The startup has developed a non-contact respiratory monitoring system that utilizes passive sensors to track a variety of respiratory symptoms and environmental metrics in a home setting. This technology enables pharmaceutical companies to enhance revenue from their products while optimizing and scaling clinical studies with objective, real-time data.
Funding: $4.2M
Rough estimate of the amount of funding raised
Funding: $4.2M
Rough estimate of the amount of funding raised
Apian provides an API that integrates drone technology into healthcare logistics, enabling on-demand delivery of medical supplies across urban and remote locations. The platform facilitates faster and more efficient distribution of critical items, such as prescription medications and blood packs, while reducing carbon emissions associated with traditional delivery methods.
Funding: $6.8M
Rough estimate of the amount of funding raised
Funding: $6.8M
Rough estimate of the amount of funding raised
deepc provides deepcOS, an operating system for radiology AI that centralizes deployment, orchestration, and integration of various AI solutions. This platform streamlines clinical workflows by securely connecting AI models to existing healthcare IT systems. The value lies in offering a scalable, unified infrastructure for building, evaluating, deploying, and monitoring medical imaging AI applications.
Funding: $13.0M
Rough estimate of the amount of funding raised
Funding: $13.0M
Rough estimate of the amount of funding raised
Doccla offers tech-agnostic virtual wards that utilize digital health tools and data analytics for remote patient monitoring and management. This system enables healthcare providers to monitor patients in real-time from their homes, alleviating hospital overcrowding and improving patient care.
Funding: $72.5M
Rough estimate of the amount of funding raised
Funding: $72.5M
Rough estimate of the amount of funding raised
Feebris provides AI-guided tools that enable community and family care workers to capture and share precise health measurements, facilitating timely clinical decision-making for vulnerable patients. The platform enhances remote monitoring by integrating data from multiple medical devices, improving patient outcomes and reducing unnecessary emergency admissions.
Funding: $8.9M
Rough estimate of the amount of funding raised
Funding: $8.9M
Rough estimate of the amount of funding raised
Hypervision Surgical Ltd utilizes AI-powered hyperspectral imaging to provide real-time, non-invasive tissue characterization during surgeries, enhancing the precision of intraoperative decision-making. This technology addresses the challenge of subjective visual assessments by enabling clinicians to differentiate between tumor and healthy tissue, ultimately improving patient safety and surgical outcomes.
Funding: $8.8M
Rough estimate of the amount of funding raised
Funding: $8.8M
Rough estimate of the amount of funding raised
iFAST Diagnostics develops a rapid Antimicrobial Susceptibility Testing (AST) system that delivers results in under four hours from blood or urine samples, significantly reducing the time to identify effective antibiotics. This technology addresses the critical issue of antimicrobial resistance by providing precise drug susceptibility data, which helps prevent the inappropriate use of antibiotics and improves patient outcomes.
Funding: $12.7M
Rough estimate of the amount of funding raised
Funding: $12.7M
Rough estimate of the amount of funding raised
This platform uses computer vision and AI to analyze patient movements in videos, providing objective metrics of Parkinson's symptoms like tremors and bradykinesia. The technology helps researchers track and score motor assessments for Parkinson's patients.
Hospitals manage dozens of internal helpdesks and thousands of external suppliers, forcing staff to navigate multiple phone lines, emails, and paper logs to report routine operational issues. This fragmented communication leads to delayed repairs, inefficient workflows, and contributes to non‑clinical surgery cancellations. MediShout delivers a unified mobile platform that consolidates all hospital helpdesks and supplier contacts into a single “one‑stop” app.
Funding: $9.0M
Rough estimate of the amount of funding raised
Funding: $9.0M
Rough estimate of the amount of funding raised
Nephrolyx provides the IVDx system, combining an IVD kit with a digital platform for routine Glomerular Filtration Rate (GFR) measurement. This solution utilizes the Iohexol-Plasma-Clearance method to deliver precise, same-day mGFR results for clinical settings. The offering supports physicians in accurate renal disease detection and optimized patient treatment planning, while streamlining laboratory workflows.
The startup operates a healthcare workforce platform that connects healthcare organizations with local staff banks to enhance temporary staffing fill rates. This platform improves patient safety and ensures adequate staffing levels in clinical services by facilitating direct access to qualified healthcare workers.
Funding: $41.4M
Rough estimate of the amount of funding raised
Funding: $41.4M
Rough estimate of the amount of funding raised
Phare Health develops AI tools that analyze complete EHR data to improve medical coding accuracy and compliance. The platform generates submission-ready code suggestions and query lists supported by evidence trails. This technology streamlines revenue cycle management by automating reviews and providing analytics on coding quality and financial performance.
Funding: $2.7M
Rough estimate of the amount of funding raised
Funding: $2.7M
Rough estimate of the amount of funding raised
The startup has developed a digital health platform that integrates a smartphone app with a physical test chip to analyze key biomarkers from a single drop of blood. This technology provides individuals with real-time insights into lifestyle diseases, enabling personalized health assessments and tailored care pathways.
30+
3K+Approximate amount of employees
Funding: $16.4M
Rough estimate of the amount of funding raised
Funding: $16.4M
Rough estimate of the amount of funding raised
TympaHealth offers the Tympa Platform, an all-in-one ear and hearing healthcare system that includes a high-definition digital otoscope, a microsuction wax removal tool, and a hearing assessment feature, all in a portable format. This platform enables healthcare providers to deliver efficient ear and hearing care in a single appointment, reducing patient wait times and improving access to essential services.
Funding: $49.6M
Rough estimate of the amount of funding raised
Funding: $49.6M
Rough estimate of the amount of funding raised
WeWALK offers a smart cane that combines a traditional mobility aid with voice‑activated AI, real‑time obstacle detection, and built‑in navigation controls. The device provides audible and haptic alerts, localized recommendations, and a flashlight, enabling users with visual impairments to travel more independently without needing to handle a phone.